RADX is Radiopharm Theranostics Limited (Healthcare) — a non-dividend-paying stock. Trading at $2.08. Market cap: $30M.
Stock snapshot
| Price | $2.08 |
| Market cap | $30M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About RADX
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Related non-dividend companies
Other non-dividend stocks investors research alongside RADX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is RADX's current stock price?
RADX (Radiopharm Theranostics Limited) is currently trading at $2.08.
Does RADX pay a dividend?
RADX (Radiopharm Theranostics Limited) does not currently pay a regular dividend.
Track RADX in DiviDrip
Add RADX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search RADX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.